Alcon Buys VC-Backed Optonol
Alcon (NYSE: ACL) has agreed to acquire Optonol Ltd., a maker of miniature surgical implants used to lower intraocular pressure (IOP) in patients with glaucoma. No financial terms were disclosed for the deal, which is expected to close in Q1 2010. Optonol had raised VC funding from Pitango Venture Capital.
14 December 2009•3 mins read
